Get started
Author

Johan Rosell

Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, phase 3 trial
2012 · Annika Malmström, Bjørn Henning Grønberg, et al. · The Lancet Oncology · 1,280
Swedish Two-County Trial: Impact of Mammographic Screening on Breast Cancer Mortality during 3 Decades
2011 · László Tabár, Bedrich Vitak, et al. · Radiology · 795
Reliability of death certificates in prostate cancer patients
2008 · Katja Fall, Fredrik Strömberg, et al. · Scandinavian Journal of Urology and Nephrology · 116
Clinical Consequences of Screening for Prostate Cancer: 15 Years Follow-up of a Randomised Controlled Trial in Sweden
2004 · Gabriel Sandblom, Eberhard Varenhorst, et al. · European Urology · 100
Coronary Heart Disease Mortality After 5 Years of Adjuvant Tamoxifen Therapy: Results from a Randomized Trial
2005 · Bo Nordenskjöld, Johan Rosell, et al. · JNCI Journal of the National Cancer Institute · 72
Survival in prostate carcinoma—Outcomes from a prospective, population‐based cohort of 8887 men with up to 15 years of follow‐up
2005 · Gunnar Aus, David Robinson, et al. · Cancer · 64
Prophylactic training for the prevention of radiotherapy-induced trismus – a randomised study
2014 · Vera Loorents, Johan Rosell, et al. · Acta Oncologica · 53
PDF
PET/CT versus conventional CT for detection of lymph node metastases in patients with locally advanced bladder cancer
2015 · Firas Aljabery, Gunnar Lindblom, et al. · BMC Urology · 48
PDF
Impact of surgical experience on recurrence and progression after transurethral resection of bladder tumour in non-muscle-invasive bladder cancer
2013 · Georg Jancke, Johan Rosell, et al. · Scandinavian Journal of Urology · 45
Health-related quality of life up to 1 year after radiotherapy in patients with head and neck cancer (HNC)
2016 · Vera Loorents, Johan Rosell, et al. · SpringerPlus · 40
PDF
Prognostic value of O‐6‐methylguanine–DNA methyltransferase (MGMT) protein expression in glioblastoma excluding nontumour cells from the analysis
2017 · R. H. Dahlrot, J. Dowsett, et al. · Neuropathology and Applied Neurobiology · 38
Long-term follow-up of conservatively managed incidental carcinoma of the prostate A multivariate analysis of prognostic factors
2007 · David Robinson, Gunnar Aus, et al. · Scandinavian Journal of Urology and Nephrology · 37
Population-based study on prognostic factors for recurrence and progression in primary stage T1 bladder tumours
2012 · Hans Olsson, Per Hultman, et al. · Scandinavian Journal of Urology · 35
Long-term effects on the incidence of second primary cancers in a randomized trial of two and five years of adjuvant tamoxifen
2017 · Johan Rosell, Bo Nordenskjöld, et al. · Acta Oncologica · 32
PDF
Prognostic Factors and Survival in Node-Positive (N1) Prostate Cancer—A Prospective Study Based on Data from a Swedish Population-Based Cohort
2003 · Gunnar Aus, Kerstin Nordenskjöld, et al. · European Urology · 29
Effects of adjuvant tamoxifen therapy on cardiac disease: results from a randomized trial with long-term follow-up
2013 · Johan Rosell, Bo Nordenskjöld, et al. · Breast Cancer Research and Treatment · 27
Swedish National Registry of Urinary Bladder Cancer: No difference in relative survival over time despite more aggressive treatment
2015 · Staffan Jahnson, Abolfazl Hosseini Aliabad, et al. · Scandinavian Journal of Urology · 26
Postoperative neoadjuvant temozolomide before radiotherapy versus standard radiotherapy in patients 60 years or younger with anaplastic astrocytoma or glioblastoma: a randomized trial
2017 · Annika Malmström, Hans Skovgaard Poulsen, et al. · Acta Oncologica · 24
PDF
Sex Disparities in MGMT Promoter Methylation and Survival in Glioblastoma: Further Evidence from Clinical Cohorts
2021 · Anja Smits, Malgorzata Lysiak, et al. · Journal of Clinical Medicine · 21
PDF
Impact of tumour size on recurrence and progression in Ta/T1 carcinoma of the urinary bladder
2011 · Georg Jancke, Johan Rosell, et al. · Scandinavian Journal of Urology and Nephrology · 21
Impact of PINCH expression on survival in colorectal cancer patients
2011 · Jasmine Lööf, Johan Rosell, et al. · BMC Cancer · 20
PDF
Second-look resection for primary stage T1 bladder cancer: a population-based study
2017 · Oliver Patschan, Sten Holmäng, et al. · Scandinavian Journal of Urology · 19
Residual tumour in the marginal resection after a complete transurethral resection is associated with local recurrence in Ta/T1 urinary bladder cancer
2012 · Georg Jancke, Johan Rosell, et al. · Scandinavian Journal of Urology and Nephrology · 19
MDM2 SNP309 promoter polymorphism and p53 mutations in urinary bladder carcinoma stage T1
2013 · Hans Olsson, Per Hultman, et al. · BMC Urology · 17
PDF
Immunohistochemical Evaluation of Cell Cycle Regulators: Impact on Predicting Prognosis in Stage T1 Urinary Bladder Cancer
2012 · Hans Olsson, Per Hultman, et al. · ISRN Urology · 15
PDF
Works count: 56
Citation count: 3,137
H-index: 20
I10-index: 31
Year
Topic
Type